StockTipsArenaBeta

BUY Ajanta Pharma Limited — Prabhudas Lilladher

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)1 Nov 2026via Moneycontrol Broker Research

Entry₹3,477.3Inferred
Target₹4,250
Total upside +22.22%
Stop lossNot given
CMP₹3,2841d ago
Active-5.56%+29.42%upside left 12 mo left
Follow Prabhudas Lilladher for new calls(71% target hit, 430 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 4 other Long-term calls on AJANTPHARMSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:41 am IST
11 supporting2 neutral3 opposing
Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·1 Nov · 2w ago

Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

NewsCnbc-Tv18·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix

NewsNdtv-Profit·2 Nov · 2w ago

(opens in new tab)

Pls find enclosed Financial Results for the quarter ended 30.09.2026.

BSE · Board Meeting·30 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Prabhudas Lilladher

Every call and its outcome